相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Primary and Metastatic Parathyroid Malignancies: A Rare or Underdiagnosed Condition?
Alexander Shifrin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
TET proteins and the control of cytosine demethylation in cancer
Laurianne Scourzic et al.
GENOME MEDICINE (2015)
TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway
F. Neri et al.
ONCOGENE (2015)
Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers
Michael Christoph Haffner et al.
Oncotarget (2015)
Understanding the Genetic Basis of Parathyroid Carcinoma
Anthony J. Gill
ENDOCRINE PATHOLOGY (2014)
The histone methyltransferase EZH2, an oncogene common to benign and malignant parathyroid tumors
Jessica Svedlund et al.
ENDOCRINE-RELATED CANCER (2014)
TET1 is a maintenance DNA demethylase that prevents methylation spreading in differentiated cells
Chunlei Jin et al.
NUCLEIC ACIDS RESEARCH (2014)
Connections between TET proteins and aberrant DNA modification in cancer
Yun Huang et al.
TRENDS IN GENETICS (2014)
Dynamic Readers for 5-(Hydroxy)Methylcytosine and Its Oxidized Derivatives
Cornelia G. Spruijt et al.
CELL (2013)
Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation
H. Yang et al.
ONCOGENE (2013)
Decrease of 5-Hydroxymethylcytosine Is Associated with Progression of Hepatocellular Carcinoma through Downregulation of TET1
Chungang Liu et al.
PLOS ONE (2013)
HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis
Miao Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
TET1 plays an essential oncogenic role in MLL-rearranged leukemia
Hao Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer
Filomena Cetani et al.
ENDOCRINE CONNECTIONS (2013)
Reduction of DNA hydroxymethylation in the mouse kidney insulted by ischemia reperfusion
Ning Huang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation
Yotaro Kudo et al.
CANCER SCIENCE (2012)
Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma
Christine Guo Lian et al.
CELL (2012)
Low values of 5-hydroxymethylcytosine (5hmC), the sixth base, are associated with anaplasia in human brain tumors
Theo F. J. Kraus et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
TET1 Suppresses Cancer Invasion by Activating the Tissue Inhibitors of Metalloproteinases
Chih-Hung Hsu et al.
CELL REPORTS (2012)
5-Hydroxymethylcytosine Is Strongly Depleted in Human Cancers but Its Levels Do Not Correlate with IDH1 Mutations
Seung-Gi Jin et al.
CANCER RESEARCH (2011)
Reprogramming of the paternal genome upon fertilization involves genome-wide oxidation of 5-methylcytosine
Khursheed Iqbal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine
Shinsuke Ito et al.
SCIENCE (2011)
Clinical and molecular genetics of parathyroid neoplasms
John M. Sharretts et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Aberrant WNT/β-catenin signaling in parathyroid carcinoma
Jessica Svedlund et al.
MOLECULAR CANCER (2010)
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Mamta Tahiliani et al.
SCIENCE (2009)
Molecular Genetics of Parathyroid Disease
Gunnar Westin et al.
WORLD JOURNAL OF SURGERY (2009)
Nonfunctioning parathyroid cancer presenting as a cervical mass
Simon Grodski et al.
THYROID (2008)
Parafibromin immunoreactivity:: its use as an additional diagnostic marker for parathyroid tumor classification
C. C. Juhlin et al.
ENDOCRINE-RELATED CANCER (2007)
Trends in the incidence and treatment of parathyroid cancer in the United States
Peter K. Lee et al.
CANCER (2007)
Activated β-catenin in the novel human parathyroid tumor cell line sHPT-1
P. Bjorklund et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma
TM Shattuck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome
JD Carpten et al.
NATURE GENETICS (2002)
分享论文
